Azora Therapeutics, Inc. (DE) (AZR) — Institutional Holders, Q3 2026
22 institutional investment managers reported a AZR position on SEC Form 13F-HR for the quarter ended September 30, 2026, with a combined reported value of $2.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
AZR in Q3 2026: what funds did
Funds that filed a 13F for both Q2 2026 and Q3 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- KVP Capital AdvisorsNew · +210,256 sh+$843.1K
- DIADEMA PARTNERSNew · +181,890 sh+$729.4K
- ACUTA CAPITAL PARTNERSNew · +129,982 sh+$521.2K
- XTX Topco LtdNew · +26,771 sh+$107.4K
- JANE STREET GROUPAdded · +21,833 sh+$87.6K
Biggest sellers
- Stonepine Capital ManagementSold out · -727,563 sh-$2.9M
- StoneX GroupSold out · -19,699 sh-$79.0K
- UBS Group AGTrimmed · -17,459 sh-$70.0K
- HARBOUR INVESTMENTSSold out · -3 sh-$12.00
- SBI Securities , Ltd.Trimmed · -2 sh-$8.00
AZR 13F holders ranked 1–22 of 22
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q2 2026 |
|---|---|---|---|---|---|
| 1 | KVP Capital Advisors#1 · 210,256 sh | 210,256 | $843.1K | 0.68% | New |
| 2 | DIADEMA PARTNERS#2 · 181,890 sh | 181,890 | $729.4K | 0.09% | New |
| 3 | ACUTA CAPITAL PARTNERS#3 · 129,982 sh | 129,982 | $521.2K | 0.40% | New |
| 4 | JANE STREET GROUP#4 · 53,952 sh | 53,952 | $216.3K | 0.00% | +68.0% |
| 5 | CITADEL ADVISORS#5 · 29,753 sh | 29,753 | $119.3K | 0.00% | +0.7% |
| 6 | XTX Topco Ltd#6 · 26,771 sh | 26,771 | $107.4K | <0.01% | New |
| 7 | GEODE CAPITAL MANAGEMENT#7 · 21,546 sh | 21,546 | $86.4K | 0.00% | +73.9% |
| 8 | VANGUARD FIDUCIARY#8 · 15,879 sh | 15,879 | $63.7K | 0.00% | +170.1% |
| 9 | China Universal Asset Management , Ltd.#9 · 12,800 sh | 12,800 | $53.1K | <0.01% | +60.0% |
| 10 | VANGUARD CAPITAL MANAGEMENT#10 · 10,407 sh | 10,407 | $41.7K | 0.00% | +78.5% |
| 11 | Manchester Capital Management#11 · 1,923 sh | 1,923 | $7.7K | <0.01% | 0.0% |
| 12 | Tower Research Capital (TRC)#12 · 1,777 sh | 1,777 | $7.1K | <0.01% | +25.2% |
| 13 | UBS Group AG#13 · 1,688 sh | 1,688 | $6.8K | 0.00% | -91.2% |
| 14 | BARCLAYS PLC#14 · 1,094 sh | 1,094 | $4.4K | 0.00% | New |
| 15 | BlackRock#15 · 304 sh | 304 | $1.2K | 0.00% | 0.0% |
| 16 | RAFFA WEALTH MANAGEMENT#16 · 83 sh | 83 | $333.00 | 0.00% | 0.0% |
| 17 | MORGAN STANLEY#17 · 50 sh | 50 | $201.00 | 0.00% | 0.0% |
| 18 | SBI Securities , Ltd.#18 · 45 sh | 45 | $180.00 | 0.00% | -4.3% |
| 19 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT#19 · 30 sh | 30 | $120.00 | 0.00% | New |
| 20 | Caitong International Asset Management , Ltd#20 · 9 sh | 9 | $36.00 | 0.00% | New |
| 21 | WELLS FARGO & COMPANY#21 · 6 sh | 6 | $24.00 | 0.00% | 0.0% |
| 22 | Abound Wealth Management#22 · 1 sh | 1 | $5.00 | 0.00% | 0.0% |
Funds that sold out of AZR in Q3 2026 (3)
Held AZR at the end of Q2 2026 and filed a Q3 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q2 2026 |
|---|---|---|
| Stonepine Capital Management727,563 sh | 727,563 | $1.6M |
| StoneX Group19,699 sh | 19,699 | $35.7K |
| HARBOUR INVESTMENTS3 sh | 3 | $8.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q3 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q2 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.